<DOC>
	<DOCNO>NCT00642694</DOCNO>
	<brief_summary>Hypothesis I : Patients SSRI + ramelteon treatment group achieve remission ( define IDS-C30 score 11 less ) quickly SSRI + placebo group .</brief_summary>
	<brief_title>Time Remission Depressive Symptoms With Combined SSRI Ramelteon</brief_title>
	<detailed_description>The primary objective study assess time remission depression initial insomnia use SSRI antidepressant escitalopram combine ramelteon placebo . Patients assess visit depressive symptom insomnia , use 30-item Inventory Depressive Symptoms , Clinician-Rated version ( IDS-C30 ; Rush et al 1986 ; Rush et al. , 1996 ) primary outcome measure . The IDS self-report version use assess self-reported change symptom severity . The 17 item Hamilton Rating Scale Depression , ( HRSD17 ; Hamilton , 1960 ) also administer , commonly utilized depression symptom severity measure time .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Ability willingness provide write informed consent . Primary diagnosis MDD initial insomnia . Age 1870 . Screening HRSD17 score great equal 16 CGIS score least 4 . Subjective report difficulty initial insomnia score 2 great IDSC30 item address symptom ( # 1 ) . Middle late insomnia may also present long initial insomnia present . Presence significant comorbid medical condition base laboratory test , physician information , evidence examination ; include severe sleep apnea , seizure disorder , chronic obstructive pulmonary disease ( COPD ) . Patient report evidence ( base physical examination laboratory test ) significant medical abnormality ; include severe sleep apnea , seizure disorder , COPD . Presence psychological disorder , include depression due comorbid condition , currently suicidal high suicide risk , current past psychotic disorder type , bipolar disorder ( I , II , NOS ) , schizophrenia , schizoaffective disorder , anorexia , bulimia , obsessive compulsive disorder , alcohol substance abuse within last 6 month , patient comorbid psychiatric condition relative absolute contraindication use escitalopram ramelteon . Concomitant ( i.e . within 2 week ; 4 week fluoxetine MAOIs ) pharmacological psychotherapeutic treatment include limited anxiolytic , neuroleptic , mood stabilizer , sleep aid include counter melatonin , and/or agent without proven antidepressant efficacy , cognitive behavioral therapy ; current use medication would contraindicate ramelteon escitalopram , , determine study doctor . Failure respond 2 adequate course SSRI class antidepressant current episode ( measure Antidepressant Treatment History Form ) . Hospitalization mental illness within past year . For woman , currently pregnant , plan become pregnant next year , breastfeed . Patient speak English . ( Patient need fluent write oral English assessment available and/or validate language English ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>MDD</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Initial Insomnia</keyword>
	<keyword>sleep</keyword>
	<keyword>difficulty sleep</keyword>
	<keyword />
	<keyword>sad</keyword>
	<keyword>Major Depressive Disorder ( MDD ) initial insomnia</keyword>
</DOC>